A detailed history of Imc Chicago, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Imc Chicago, LLC holds 207,765 shares of OCUL stock, worth $2.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
207,765
Holding current value
$2.4 Million
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 22, 2025

BUY
$6.02 - $9.46 $1.25 Million - $1.97 Million
207,765 New
207,765 $1.93 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $889M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Imc Chicago, LLC Portfolio

Follow Imc Chicago, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.